# Phioanh L. Nghiemphu

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/phioanh-l-nghiemphu/

## Facts

| Field | Value |
| --- | --- |
| Citations | 12,247 |
| Field | Glioma Diagnosis and Treatment |
| h-index | 57 |
| i10-index | 127 |
| Last Known Institution | University of Minnesota |
| OpenAlex ID | https://openalex.org/A5038569402 |
| ORCID iD | 0000-0003-4064-6079 |
| Works | 334 |

## Researcher papers

- [Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma](https://scholariq.org/papers/neoadjuvant-anti-pd-1-immunotherapy-promotes-a-survival-benefit-with/)
- [Antitumor Activity of Rapamycin in a Phase I Trial for Patients with Recurrent PTEN-Deficient Glioblastoma](https://scholariq.org/papers/antitumor-activity-of-rapamycin-in-a-phase-i-trial-for-patients-with-recurrent/)
- [Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme](https://scholariq.org/papers/phase-ii-study-of-bevacizumab-plus-temozolomide-during-and-after-radiation/)
- [Evidence for Sequenced Molecular Evolution of <i>IDH1</i> Mutant Glioblastoma From a Distinct Cell of Origin](https://scholariq.org/papers/evidence-for-sequenced-molecular-evolution-of-i-idh1-i-mutant-glioblastoma-from/)
- [Epidermal Growth Factor Receptor Activation in Glioblastoma through Novel Missense Mutations in the Extracellular Domain](https://scholariq.org/papers/epidermal-growth-factor-receptor-activation-in-glioblastoma-through-novel/)
- [Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors](https://scholariq.org/papers/differential-sensitivity-of-glioma-versus-lung-cancer-specific-egfr-mutations-to/)
- [Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment](https://scholariq.org/papers/recurrent-glioblastoma-multiforme-adc-histogram-analysis-predicts-response-to/)
- [Relationship between Tumor Enhancement, Edema,<i>IDH1</i>Mutational Status,<i>MGMT</i>Promoter Methylation, and Survival in Glioblastoma](https://scholariq.org/papers/relationship-between-tumor-enhancement-edema-i-idh1-i-mutational-status-i-mgmt-i/)
- [MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy](https://scholariq.org/papers/mri-in-patients-with-high-grade-gliomas-treated-with-bevacizumab-and/)
- [Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy](https://scholariq.org/papers/bead-based-profiling-of-tyrosine-kinase-phosphorylation-identifies-src-as-a/)
- [Caregiver burden by treatment and clinical characteristics of patients with glioblastoma](https://scholariq.org/papers/caregiver-burden-by-treatment-and-clinical-characteristics-of-patients-with/)

## Researcher topics

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [MRI in cancer diagnosis](https://scholariq.org/topics/mri-in-cancer-diagnosis/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)
- [Advanced MRI Techniques and Applications](https://scholariq.org/topics/advanced-mri-techniques-and-applications/)
- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)

## Researcher university

- [University of Minnesota](https://scholariq.org/institutions/university-of-minnesota/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.